Free Trial

Integer (ITGR) Competitors

Integer logo
$119.80 +2.62 (+2.23%)
As of 11:27 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ITGR vs. HOLX, GMED, MASI, TFX, IART, ATRC, ATEC, OFIX, SRDX, and ANGO

Should you be buying Integer stock or one of its competitors? The main competitors of Integer include Hologic (HOLX), Globus Medical (GMED), Masimo (MASI), Teleflex (TFX), Integra LifeSciences (IART), AtriCure (ATRC), Alphatec (ATEC), Orthofix Medical (OFIX), Surmodics (SRDX), and AngioDynamics (ANGO). These companies are all part of the "health care equipment" industry.

Integer vs.

Hologic (NASDAQ:HOLX) and Integer (NYSE:ITGR) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, media sentiment, analyst recommendations, community ranking, earnings, valuation and risk.

Hologic has a net margin of 18.42% compared to Integer's net margin of 6.92%. Hologic's return on equity of 19.72% beat Integer's return on equity.

Company Net Margins Return on Equity Return on Assets
Hologic18.42% 19.72% 10.94%
Integer 6.92%11.65%5.89%

In the previous week, Hologic had 17 more articles in the media than Integer. MarketBeat recorded 28 mentions for Hologic and 11 mentions for Integer. Hologic's average media sentiment score of 1.11 beat Integer's score of 0.84 indicating that Hologic is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hologic
19 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive
Integer
4 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Hologic received 491 more outperform votes than Integer when rated by MarketBeat users. Likewise, 69.32% of users gave Hologic an outperform vote while only 63.93% of users gave Integer an outperform vote.

CompanyUnderperformOutperform
HologicOutperform Votes
881
69.32%
Underperform Votes
390
30.68%
IntegerOutperform Votes
390
63.93%
Underperform Votes
220
36.07%

94.7% of Hologic shares are held by institutional investors. Comparatively, 99.3% of Integer shares are held by institutional investors. 1.9% of Hologic shares are held by insiders. Comparatively, 2.0% of Integer shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Hologic has a beta of 0.97, indicating that its share price is 3% less volatile than the S&P 500. Comparatively, Integer has a beta of 1.24, indicating that its share price is 24% more volatile than the S&P 500.

Hologic currently has a consensus target price of $84.62, indicating a potential upside of 36.72%. Integer has a consensus target price of $149.00, indicating a potential upside of 27.20%. Given Hologic's higher possible upside, equities analysts plainly believe Hologic is more favorable than Integer.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hologic
0 Sell rating(s)
11 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.41
Integer
0 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.75

Hologic has higher revenue and earnings than Integer. Hologic is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hologic$4.04B3.44$789.50M$3.1719.52
Integer$1.72B2.29$90.65M$3.3634.86

Summary

Hologic beats Integer on 12 of the 19 factors compared between the two stocks.

Remove Ads
Get Integer News Delivered to You Automatically

Sign up to receive the latest news and ratings for ITGR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ITGR vs. The Competition

MetricIntegerElectromedical equipment IndustryMedical SectorNYSE Exchange
Market Cap$3.94B$3.34B$5.74B$19.77B
Dividend YieldN/A1.61%4.55%3.75%
P/E Ratio34.8615.6324.7034.14
Price / Sales2.2942.93396.6128.93
Price / Cash15.1844.0938.1617.54
Price / Book2.433.417.154.65
Net Income$90.65M$94.03M$3.20B$1.02B
7 Day Performance-1.46%1.74%3.62%1.47%
1 Month Performance-8.54%-8.00%7.40%-0.75%
1 Year Performance2.45%-9.07%15.60%7.33%

Integer Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ITGR
Integer
2.6873 of 5 stars
$119.77
+2.2%
$149.00
+24.4%
+0.9%$4.02B$1.72B35.6310,500
HOLX
Hologic
4.9472 of 5 stars
$61.82
+1.8%
$84.62
+36.9%
-17.8%$13.87B$4.04B19.507,063Analyst Revision
Positive News
GMED
Globus Medical
4.8416 of 5 stars
$72.16
+1.6%
$97.82
+35.5%
+46.1%$9.93B$2.52B96.225,000
MASI
Masimo
3.6935 of 5 stars
$172.78
+2.7%
$194.80
+12.7%
+24.2%$9.32B$2.09B119.166,200Positive News
Gap Up
TFX
Teleflex
4.8403 of 5 stars
$139.60
+1.4%
$182.63
+30.8%
-35.9%$6.47B$3.05B27.7514,500
IART
Integra LifeSciences
2.7566 of 5 stars
$23.12
+3.4%
$23.00
-0.5%
-32.9%$1.79B$1.61B-256.863,946
ATRC
AtriCure
3.6553 of 5 stars
$33.78
+1.4%
$51.56
+52.6%
+23.3%$1.65B$465.31M-35.561,300
ATEC
Alphatec
4.2801 of 5 stars
$9.75
+5.0%
$17.67
+81.2%
-20.7%$1.41B$611.56M-7.62700Positive News
OFIX
Orthofix Medical
3.1939 of 5 stars
$16.78
+1.5%
$23.33
+39.1%
+24.6%$654.79M$799.49M-5.361,090
SRDX
Surmodics
4.4479 of 5 stars
$29.01
+2.5%
$50.00
+72.4%
+10.0%$414.73M$125.45M-28.72450Analyst Revision
ANGO
AngioDynamics
4.2116 of 5 stars
$9.59
+6.4%
$13.00
+35.6%
+88.1%$388.07M$286.50M-1.70760
Remove Ads

Related Companies and Tools


This page (NYSE:ITGR) was last updated on 3/25/2025 by MarketBeat.com Staff
From Our Partners